OPIPZA Drug Patent Profile
✉ Email this page to a colleague
When do Opipza patents expire, and when can generic versions of Opipza launch?
Opipza is a drug marketed by Xiamen Lp Pharm Co and is included in one NDA.
The generic ingredient in OPIPZA is aripiprazole. There are forty-nine drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Opipza
A generic version of OPIPZA was approved as aripiprazole by ALEMBIC on April 28th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OPIPZA?
- What are the global sales for OPIPZA?
- What is Average Wholesale Price for OPIPZA?
Summary for OPIPZA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in OPIPZA? | OPIPZA excipients list |
| DailyMed Link: | OPIPZA at DailyMed |
Pharmacology for OPIPZA
| Drug Class | Atypical Antipsychotic |
US Patents and Regulatory Information for OPIPZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiamen Lp Pharm Co | OPIPZA | aripiprazole | FILM;ORAL | 216655-001 | Jul 22, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xiamen Lp Pharm Co | OPIPZA | aripiprazole | FILM;ORAL | 216655-002 | Jul 22, 2024 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xiamen Lp Pharm Co | OPIPZA | aripiprazole | FILM;ORAL | 216655-003 | Jul 22, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
